Author: Steve Shafer, MD, FASA, Editor-in-Chief ASA Monitor June 2023, Vol. 87, 1–4. Death from the COVID-19 pandemic was not limited to mortality from respiratory illness. According to the National Institute on Drug Abuse, more than 68,000 died from opioid overdose in 2020, and more than 80,000 died from opioid overdose in 2021 (asamonitor.pub/3mbLWqY). Surging opioid […]
Read MoreAuthor: Mariah Taylor Becker’s Clinical Leadership Twelve percent of nurse leaders plan to leave their position in the next six months, according to an American Organization for Nursing Leadership Foundation study. The 2024 Longitudinal Nursing Leadership Insight Study has surveyed leaders since July 2020. The latest report, based on a survey conducted in November 2023, included […]
Read MoreAuthors: Bruno M. Ribeiro, P.T et al Anesthesiology January 2024. Background Lower FiO2 during general anesthesia can reduce lung atelectasis. The objectives are to evaluate the effect of two FiO2 (0.4 and 1) during low PEEP ventilation over lung perfusion distribution, volume, and regional ventilation. These variables were evaluated at two PEEP levels and unilateral lung atelectasis. […]
Read MoreAuthors: Hyoungkyu Kim et al Anesthesiology January 2024. Background Although remimazolam is used as a general anesthetic in elderly patients due to its hemodynamic stability, the electroencephalogram (EEG) characteristics of remimazolam are not well-known. The purpose of this study was to identify the EEG features of remimazolam-induced unconsciousness in elderly patients and compare them with […]
Read MoreAuthor: Paige Twenter Becker’s Hospital Review Hospitals should start conserving supply of short-term anesthetics as drug manufacturers become more conservative with nitrosamine measures, according to Eric Tichy, PharmD. In 2021, the FDA issued a guidance for drugmakers on controlling impurities of nitrosamine, a probable carcinogen. The guidance recommended pharmaceutical companies to fully comply by October 2023. Dr. […]
Read More